O-GlcNAcylation of the tumor suppressor LATS1 drives mitotic progression via PLK1
Journal of Biological Chemistry · 2026
DOI: 10.1016/j.jbc.2025.110990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Li Meng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing, China. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Proto-Oncogene Proteins, Cell Cycle Proteins, Mitosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Initially discovered in Drosophila, the Hippo pathway is pivotal for tissue growth and organ homeostasis. It is regulated by both extrinsic and intrinsic signals and exerts its effect via a core kinase cascade, in which large tumor suppressor 1 and 2 (LATS1/2) plays a key role. LATS1 has also been shown to regulate mitotic progression by phosphorylating myosin phosphatase targeting subunit 1 (MYPT1) to counteract the activity of polo-like kinase 1 (PLK1), a mitotic master kinase. Herein, we demonstrate that the hexosamine biosynthetic pathway regulates the Hippo pathway via LATS1. We show that LATS1 interacts with the O-GlcNAc transferase (OGT) and is O-GlcNAcylated. Via electron transfer dissociation mass spectrometry, we mapped the O-GlcNAcylation sites to be S479/S482/T484/T485. O-GlcNAcylation attenuates LATS1 protein stability and downregulates the phosphorylation level of its downstream substrates, such as MYPT1. Subsequently, decreased MYPT1-pS473 levels enhance PLK1-pT210 levels and drive mitotic progression. Importantly, we demonstrate that in Drosophila O-GlcNAcylation of LATS1 promotes the wing size. Thus, this study suggests that O-GlcNAcylation links extrinsic glucose levels to LATS1 in the Hippo pathway and cell proliferation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing, China.
- The State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin, China.
- College of Chemistry and Molecular Engineering, Peking University, Beijing, China.
- The State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin, China. Electronic address: wusa@nankai.edu.cn.
- Beijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing, China. Electronic address: jing_li@mail.cnu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Meng, L., Wang, Y., Zhou, W., Wu, S., & Li, J. (2026). O-GlcNAcylation of the tumor suppressor LATS1 drives mitotic progression via PLK1. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110990
Vancouver
Meng L, Wang Y, Zhou W, Wu S, Li J. O-GlcNAcylation of the tumor suppressor LATS1 drives mitotic progression via PLK1. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2025.110990
BibTeX
@article{Meng2026,
author = {Meng, Li and Wang, Yunfeng and Zhou, Wen and Wu, Shian and Li, Jing},
title = {O-GlcNAcylation of the tumor suppressor LATS1 drives mitotic progression via PLK1},
journal = {Journal of Biological Chemistry},
year = {2026},
doi = {10.1016/j.jbc.2025.110990}
}
EUVIMED